English
  1. Home
  2. Stocks
  3. Caplipoint Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Caplin Point Laboratories

    Mid Cap
    ₹1,314.95
    -26.35 (-1.96%)
    18 May, 2024 18:46 BSE: 524742 NSE: CAPLIPOINTISIN: INE475E01026

    Start SIP in Caplin Point Laboratories

    Start SIP

    Caplin Point Laboratories Performance

    Day Range

    • Low 1,298
    • High 1,341
    ₹ 1,314

    52 Week Range

    • Low 691
    • High 1,619
    ₹ 1,314
    • Open Price1,340
    • Previous Close1,341
    • Volume25278

    Caplin Point Laboratories Share Price

    • Over 1 Month -0.09%
    • Over 3 Month -16.37%
    • Over 6 Month +2.23%
    • Over 1 Year +85.4%

    Caplin Point Laboratories Key Statistics

    P/E Ratio 21.8
    PEG Ratio 1
    Market Cap Cr 9,986
    Price to Book Ratio 4.3
    EPS 37.4
    Dividend 0.3
    Relative Strength Index 48.03
    Money Flow Index 36.88
    MACD Signal -3.2
    Average True Range 41.93
    Caplin Point Laboratories Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 139133179174145
    Operating Expenses Qtr Cr 8270909780
    Operating Profit Qtr Cr 5863897765
    Depreciation Qtr Cr 77776
    Interest Qtr Cr 00000
    Tax Qtr Cr 1719252116
    Net Profit Qtr Cr 7055827654
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 731628
    Operating Expenses Annual Cr 338309
    Operating Profit Annual in Cr 287220
    Depreciation Cr 2726
    Interest Annual Cr 00
    Tax Annual Cr 8259
    Net Profit Annual Cr 284234
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 104157
    Cash from Investing Activity Annual Cr -112-87
    Cash from Financing Annual Activity Cr -34-30
    Net Cash Flow Annual Cr 40
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,3901,140
    Fixed Assets Annual Cr 193200
    Total Non Current Assets Annual Cr 820639
    Total Current Assets Annual Cr 703664
    Total Assets Annual Cr 1,5221,303
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 183150
    ROE Annual % 2021
    ROCE Annual % 2625
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 6360
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 453436410395389
    Operating Expenses Qtr Cr 308293273269265
    Operating Profit Qtr Cr 145142137127124
    Depreciation Qtr Cr 1614121111
    Interest Qtr Cr 00000
    Tax Qtr Cr 2526302323
    Net Profit Qtr Cr 122117115103102
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 1,7611,523
    Operating Expenses Annual Cr 1,1431,026
    Operating Profit Annual in Cr 551441
    Depreciation Cr 5345
    Interest Annual Cr 11
    Tax Annual Cr 10374
    Net Profit Annual Cr 457376
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 311271
    Cash from Investing Activity Annual Cr -313-218
    Cash from Financing Annual Activity Cr -38-28
    Net Cash Flow Annual Cr 26
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 2,3161,806
    Fixed Assets Annual Cr 568501
    Total Non Current Assets Annual Cr 805637
    Total Current Assets Annual Cr 1,8921,554
    Total Assets Annual Cr 2,6972,191
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 309241
    ROE Annual % 2021
    ROCE Annual % 2424
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3734
    Sign Up to Know More
    Invest in Caplin Point Laboratories

    Caplin Point Laboratories Technicals

    EMA & SMA

    Current Price
    ₹1,314.95
    -26.35 (-1.96%)
    pointer
    • Bullish Moving Average
    • ___
    • 4
    • Bearish Moving Average
    • ___
    • 12
    • 20 Day
    • ₹1,323.52
    • 50 Day
    • ₹1,335.11
    • 100 Day
    • ₹1,322.44
    • 200 Day
    • ₹1,227.41
    • 20 Day
    • ₹1,325.51
    • 50 Day
    • ₹1,322.33
    • 100 Day
    • ₹1,386.24
    • 200 Day
    • ₹1,239.48

    Caplin Point Laboratories Resistance and Support

    PIVOT
    ₹1,353.82
    Resistance
    First Resistance 1,377.48
    Second Resistance 1,413.67
    Third Resistance 1,437.33
    RSI 53.64
    MFI 36.33
    MACD Single Line -4.12
    MACD 1.46
    Support
    First Support 1,317.63
    Second Support 1,293.97
    Third Supoort 1,257.78

    Caplin Point Laboratories Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 152,667 7,528,010 49.31
    Week 104,844 4,170,678 39.78
    1 Month 83,498 3,784,123 45.32
    6 Month 132,969 5,922,447 44.54

    Caplin Point Laboratories Result Highlights

    Caplin Point Laboratories Synopsis

    NSE-Medical-Generic Drugs

    Caplin Point Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 528.61 Cr. and Equity Capital is Rs. 15.18 Cr. for the Year ended 31/03/2023. Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053.
    Market Cap 10,186
    Sales 625
    Shares in Float 2.20
    No of funds 127
    Yield 0.33
    Book Value 7.33
    U/D Vol ratio 0.9
    LTDebt / Equity
    Alpha 0.2
    Beta 0.71

    Caplin Point Laboratories Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 70.62%70.62%70.63%70.63%
    Mutual Funds 1.06%0.41%0.05%0.05%
    Insurance Companies 0.13%
    Foreign Portfolio Investors 3.33%2.84%3.09%2.68%
    Financial Institutions/ Banks 0.01%0.01%
    Individual Investors 17.59%18.36%18.31%18.58%
    Others 7.4%7.77%7.78%8.05%

    Caplin Point Laboratories Management

    Name Designation
    Mr. C C Paarthipan Chairman
    Dr. Sridhar Ganesan Managing Director
    Dr. R Nagendran Independent Director
    Mr. S Deenadayalan Independent Director
    Mr. D Sathyanarayanan Independent Director
    Dr. C K Gariyali Independent Director

    Caplin Point Laboratories Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Caplin Point Laboratories Corporate Action

    Date Purpose Remarks
    2024-05-16 Audited Results & Interim Dividend
    2024-02-09 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-07 Quarterly Results, Final Dividend & A.G.M.
    2023-05-27 Audited Results & Interim Dividend (Revised) per share(110%)Final Dividend
    Date Purpose Remarks
    2024-05-31 INTERIM Rs.2.50 per share(125%)Interim Dividend
    2023-06-09 INTERIM Rs.2.00 per share(100%)Interim Dividend
    2022-05-24 INTERIM Rs.2.00 per share(100%)Interim Dividend
    2021-05-19 INTERIM Rs.1.50 per share(75%)Interim Dividend

    Caplin Point Laboratories MF Shareholding

    Name Amount(cr)
    UTI Aggressive Hybrid Fund Regular Plan Growth 5,488
    UTI Retirement Fund - Regular Plan 4,384
    UTI Small Cap Fund Regular Growth 3,791
    UTI Large & Mid Cap Fund Regular Plan Growth 2,978
    Nippon India Nifty Smallcap 250 Index Fund Reg Gr 1,260

    Caplin Point Laboratories FAQs

    What is Share Price of Caplin Point Laboratories ?

    Caplin Point Laboratories share price is ₹1,314 As on 18 May, 2024 | 18:32

    What is the Market Cap of Caplin Point Laboratories ?

    The Market Cap of Caplin Point Laboratories is ₹9986 Cr As on 18 May, 2024 | 18:32

    What is the P/E ratio of Caplin Point Laboratories ?

    The P/E ratio of Caplin Point Laboratories is 21.8 As on 18 May, 2024 | 18:32

    What is the PB ratio of Caplin Point Laboratories ?

    The PB ratio of Caplin Point Laboratories is 4.3 As on 18 May, 2024 | 18:32

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.